Trialect

Active

Clinical Genetics, Genomics, and Oncology

Clinical Laboratory Director of Molecular Diagnostics and Cytogenetics, Advocate Health

Dr. Aida Catic is an ABMGG board-certified Laboratory Geneticist and Genomics specialist with over 15 years of experience in clinical molecular genetics and cytogenetics. She currently serves as Clinical Laboratory Director of Molecular Diagnostics and Cytogenetics at Advocate Health, Illinois, and as an affiliated Clinical Assistant Professor at the University of Pittsburgh School of Medicine. Dr. Catic has extensive expertise in the interpretation and reporting of constitutional, prenatal, and oncologic genomic data, including cytogenetics, FISH, microarray, and next-generation sequencing. Her professional strengths include assay validation, regulatory compliance, CAP inspections, and laboratory quality management. She has led and contributed to translational research in cancer and prenatal genomics, with multiple peer-reviewed publications in high-impact journals. Dr. Catic is actively involved in teaching, clinician consultation, and interdisciplinary tumor boards, and is recognized for her commitment to advancing precision diagnostics and genomic medicine in clinical practice.

Main Areas of Interest

Clinical cytogenetics and molecular diagnostic testing
Constitutional and somatic genomic testing across the lifespan
Prenatal cytogenetic testing, including amniotic fluid and chorionic villus samples
Postnatal constitutional cytogenetic and molecular diagnostics
Somatic testing in hematologic malignancies and solid tumors, including bone marrow, leukemic blood, and tumor specimens
Integrated application of cytogenetics, FISH, microarray, and next-generation sequencing for specific clinical indications
Interpretation and clinical reporting of complex genomic abnormalities
Translational genomics in oncology and prenatal diagnostics

Specialties

Genetics & Genomics

Molecular Biology

Techniques You Will Learn

Virtual exposure to a broad range of diagnostic techniques in cytogenetics and molecular genetics through case-based learning
Interpretation of conventional cytogenetic analyses, including karyotypes from constitutional, prenatal, and oncologic cases
Clinical application and interpretation of FISH results across prenatal, postnatal, and cancer diagnostics
Genomic microarray data analysis and reporting (SNP and CGH arrays) for constitutional and somatic indications
Somatic next-generation sequencing (NGS) data review and variant interpretation for hematologic malignancies and solid tumors
Overview and interpretation of PCR-based assays, including quantitative PCR and fragment analysis
Principles and clinical use of non-invasive prenatal testing (NIPT)
Introduction to pharmacogenomics and clinical result interpretation
Integrated interpretation of multimodal genomic data using real-world clinical scenarios
Understanding laboratory workflows, quality systems, and regulatory requirements (CAP/CLIA) in a virtual laboratory setting

Modules

Module 1: Clinical Cytogenetics and Constitutional Genomics

Principles of clinical cytogenetics and molecular diagnostics
Interpretation of karyotyping, FISH, and microarray in constitutional disorders
Prenatal and postnatal samples: amniotic fluid, CVS, and peripheral blood
Case-based interpretation of aneuploidies, structural variants, and CNVs

Module 2: Prenatal and Postnatal Genomic Diagnostics

Genomic testing strategies in prenatal and early-life settings
Interpretation of non-invasive prenatal testing (NIPT)
Correlation of invasive and non-invasive prenatal results
Clinical reporting and multidisciplinary communication

Module 3: Cancer Cytogenetics and Somatic Molecular Testing

Cytogenetic and molecular testing in hematologic malignancies and solid tumors
Interpretation of karyotyping, FISH, microarray, and somatic NGS data
Analysis of bone marrow, leukemic blood, and tumor specimens
Clinical relevance of somatic genomic alterations

Module 4: Integrated Genomic Interpretation and Laboratory Practice

Integration of results across multiple testing modalities
PCR-based assays, fragment analysis, and pharmacogenomics
Laboratory workflows, quality systems, and CAP/CLIA regulations
Ethical considerations and best practices in genomic reporting

Program Fee


Total Number of Modules	6
Time duration of Each module	45 minutes
Total Program Cost	$703.13

Who Can Apply

Medical graduates and postgraduate trainees in pathology, genetics, or related disciplines

Clinical geneticists, molecular pathologists, and laboratory physicians seeking structured genomic training

PhD scholars and postdoctoral researchers in genetics, molecular biology, or genomics

Laboratory scientists and technologists working in cytogenetics or molecular diagnostics

Host Details

Host Name: Aida Catic

Affiliation: Clinical Laboratory Director of Molecular Diagnostics and Cytogenetics, Advocate Health

Address: Clinical Laboratory Director of Molecular Diagnostics and Cytogenetics, Advocate Health, Rosemont, Illinois

Website URL:

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.